Related Experiment Videos
Biologic effects of transdermal estradiol
The New England Journal of Medicine
|June 19, 1986
Summary
Transdermal estradiol and oral conjugated equine estrogens provide similar benefits for menopausal symptoms. However, transdermal estradiol avoids negative effects on liver proteins seen with oral estrogen therapy.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Estrogen therapy is used for menopausal symptom relief.
- Different administration routes may have varying physiological effects.
Purpose of the Study:
- To compare the physiological effects of transdermal estradiol and oral conjugated equine estrogens in postmenopausal women.
- To assess dose-response relationships for both administration routes.
Main Methods:
- A dose-response study involving 23 postmenopausal women.
- Administration of transdermal estradiol (25-200 mcg/24h) and oral conjugated estrogens (0.625-1.25 mg).
- Measurement of hormone levels, vaginal cell changes, urinary calcium, and hepatic protein synthesis.
Main Results:
- Both estradiol and conjugated estrogens increased estrogen levels and reduced gonadotropins.
- Both decreased vaginal parabasal cells and increased superficial cells.
- Oral estrogens increased renin substrate, SHBG, TBG, and CBG; transdermal estradiol did not.
- Oral estrogens favorably affected lipoproteins at higher doses; transdermal estradiol did not.
- Neither preparation affected clotting factors.
Conclusions:
- Transdermal estradiol offers many benefits of estrogen therapy.
- Transdermal estradiol avoids the hepatic protein alterations associated with oral estrogen.
- Estrogen administration route impacts specific physiological responses.